Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. - Wikidata - wikimedia - TriplyDB

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

http://www.wikidata.org/entity/Q44385585

about

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm Current and emerging therapies for the management of bipolar disorders Posttraumatic stress disorder, depression, and health-related quality of life in patients with bipolar disorder: review and new data from a multi-site community clinic sample.Ziprasidone: efficacy, tolerability, and emerging data on wide-ranging effectiveness.Bipolar disorder.Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials.Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis [Anticonvulsants and antipsychotics in the treatment of bipolar disorder].Weight gain, obesity, and psychotropic prescribing.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Ziprasidone in the treatment of mania in bipolar disorder.Acute and long-term treatment of mania.Effect of initial ziprasidone dose on treatment outcome of korean patients with acute manic or mixed episodes.Recent developments in the treatment of bipolar disorders.Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.Psychiatric medication-induced obesity: a review.The case for atypical antipsychotics in bipolar disorder.The pharmacology of bipolar disorder during pregnancy and breastfeeding.New medication treatment options for bipolar disorders.Quality of life among bipolar disorder patients misdiagnosed with major depressive disorder Pharmacotherapy of bipolar mixed states.Atypical antipsychotics: newer options for mania and maintenance therapy.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Safety and tolerability of emerging pharmacological treatments for bipolar disorder.Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review.Pharmacological treatment of mixed states.Emerging treatments for bipolar disorder: safety and adverse effect profiles.Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine.Anticonvulsants in the treatment of bipolar mania.Current schizophrenia drugs: efficacy and side effects.Ziprasidone: efficacy and safety in patients with bipolar disorder.Evidence review and clinical guidance for the use of ziprasidone in Canada.Emerging drugs for bipolar disorder.Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial

P2860

Q21260276-C4247EDD-F714-4694-8FC6-A682293E705E Q24601815-ECC7F31A-F46E-40D4-8AF7-5CC73C998BBD Q24643545-18327C5F-7E9C-431D-AB72-66F49CB08AC2 Q28066714-4DBC63FE-6433-4E63-876D-A343E7A3B3BD Q28686902-A753ADAC-B75E-4265-A91C-6E8C90625C79 Q30571258-D2EF71F3-40A9-4923-9AAB-7BC4F8DEC547 Q30984472-E8482498-A54A-4049-B9BE-C9DDCFAE377D Q33448290-385A0C9E-2C3C-41AB-B064-2B88CB335472 Q33518314-58768542-57CB-4626-841C-D746600DC51D Q33529314-01F3DB9F-D777-451D-AC52-60544317C468 Q34553398-5F7752FF-3091-4F3B-B940-7B550055089A Q34557537-CE6A87E0-0485-4A62-A912-DD9878B05333 Q34606256-E134D7F8-ECC2-4449-9F03-AF575E6604DB Q34649187-689E9EA9-20D2-4A9D-8835-B2F43CA40805 Q34809427-2EC7F2B9-333E-4675-B4D6-2DBA13229D4F Q34966022-22F806AB-B76A-4BA2-B5D4-C0F7F48F6148 Q35236966-5B6B6AFF-2363-4213-8561-C6CF4368B75E Q35238333-4E06DE81-F2E8-4A7C-A2B8-001FABCE53AB Q35547289-37EB1633-3D2A-4C53-8B95-8B7B582F352F Q35618427-50FB4C5A-08C3-42D1-AA5E-3F1EF324EF2B Q35618441-B71FC05C-D390-485B-8F68-055429AFC56C Q35746806-7E0A78F5-76C3-4464-AA24-6D175BA74C59 Q35775218-2A353329-8466-4B6F-812D-F921D940D937 Q35779335-212F316E-A1C2-4034-800B-BC9901493D4A Q35872066-0AEC406D-BFCB-4D86-8917-1048FFCB6BDF Q35875975-2C4656B6-7B52-4644-96AA-7F97385434C9 Q36130303-3AD57847-96D3-4C5F-879B-067E9A43D93F Q36158824-BE01C39C-B20D-4A5F-9E14-2D2B23441F32 Q36162402-D9736095-2B65-41B0-9FDD-392E2F400DED Q36199036-53AED5F4-DA90-4E1A-9F44-42470B215076 Q36274272-E9A9E3C3-A9C3-4AD2-AB88-B1964570579D Q36349023-0880A469-5B9F-4D44-8BC0-25711A8895F4 Q36364980-E4FB431C-B055-4DA7-B260-B628E7DBD6E4 Q36390795-54D7351A-E9BF-44A4-A879-7038C25A9928 Q36407359-C84458D5-FCF1-4547-859E-71E41B36568D Q36488206-B76AD887-812E-47F1-8176-9603C5AAEDDF Q36558654-CC90810F-41F0-4182-B894-D4EED75ED05D Q36588607-F92579BF-9ED3-435C-A3B8-06BB79C3620D Q36634257-F6B15C1F-5518-45DF-85CA-7AED9FB5577B Q36780394-BE981EEC-E053-4FC7-A2F7-7DA5A2D139AA

P2860

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.

http://www.wikidata.org/entity/Q44385585

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@en

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@nl

type

label

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@en

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@nl

prefLabel

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@en

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@nl

P1433

Q44385585-0E2C35E5-42C6-4DDF-A932-F8758E7B67A0

P1476

Q44385585-5F9E959C-BB0E-434C-9BBD-5104A4238D8D

P2093

Q44385585-2ACA5B3C-0C1A-4474-BB1E-A66C53B6D9F2

Q44385585-2D03F2FF-75CA-4743-BCB1-6805FF56D63D

Q44385585-4D44C6DA-777D-435D-940D-27F8F054B7A1

Q44385585-85AB94E9-66E0-4B47-8CE8-BC99DDB4EA4D

Q44385585-E3E0F256-9F66-4E07-B90B-0A767E33AA2D

Q44385585-F90200E0-1CC9-4CD0-B68C-F2E3F2597DD2

P304

Q44385585-B7E75D3C-B964-46D7-A7D8-B8C72B33BCEC

P31

Q44385585-327CC0FB-3357-45A1-8228-87F66E9499DE

P356

Q44385585-99FB3A4C-026D-44EE-8F5A-8181E78920A2

P407

Q44385585-616B9401-DEE6-4243-B87E-A85EA0789893

P433

Q44385585-21F0CDA0-FA08-4D17-B6EA-170BDE129103

P478

Q44385585-311A5CED-F5EA-45C7-881B-803CCCC87B3C

P50

Q44385585-701892EF-F872-4E57-A333-785D0437258E

P577

Q44385585-E9D2DC42-CCE8-4B50-B022-6BBB5E8508FD

P5875

Q44385585-536D2A4F-9B13-4F17-ACAB-31C148396563

P698

Q44385585-DF4C55BC-A39B-40F5-BEB3-616C84AABF5D

P921

Q44385585-C5998648-1ED0-4B4F-AD4F-630314B61FA0

P356

APPI.AJP.160.4.741

P1433

American Journal of Psychiatry

P1476

Ziprasidone in the treatment o ...... ouble-blind, randomized trial.

@en

P2093

Earl Giller

http://www.w3.org/2001/XMLSchema#string

Kathleen Ice

http://www.w3.org/2001/XMLSchema#string

Marcio Versiani

http://www.w3.org/2001/XMLSchema#string

Paul E Keck

http://www.w3.org/2001/XMLSchema#string

Scott A West

http://www.w3.org/2001/XMLSchema#string

Ziprasidone in Mania Study Group

http://www.w3.org/2001/XMLSchema#string

P304

741-748

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.160.4.741

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

Steven G Potkin

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10828756

http://www.w3.org/2001/XMLSchema#string

P698

12668364

http://www.w3.org/2001/XMLSchema#string

P921